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ABSTRACT
Proper nutrition is an important element that determines the course of pregnancy. Unfortunately, the everyday diet is not 
always able to cover the increased in pregnancy essential vitamins and minerals requirements. Therefore, pregnant women 
often use dietary supplements. This study aimed to compare Polish and international recommendations regarding dietary 
supplementation during pregnancy. The Polish Society of Gynaecologists and Obstetricians (PSGO) recommends in every 
pregnant woman the dietary supplementation of folates, vitamin D and iodine.
Additionally, the benefits of iron supplementation in pregnant women with anemia or at high risk of developing anemia 
are also highlighted. In the light of Polish guidelines, the magnesium supplementation is recommended in the condition 
of its reduced level in blood. In the case of limited consumption of DHA (docosahexaenoic acid), Polish guidelines recom-
mend in pregnant women’s diet, at least 600 mg of DHA every day. Still, in case of the high risk of premature birth — at 
least 1000 mg DHA a day during the entire pregnancy period should be taken. 
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INTRODUCTION
Diet supplements cover a wide range of products which, 
due to their vast diversity, are hard to be precisely defined. 
Still, there is no consensus of international societies and 
scientific bodies regarding the definition of diet supple-
ments, and the preparations that should be included in this 
group. Polish legal regulations specify that a diet supple-
ment is “a food product whose purpose is to supplement 
the standard diet. Being a concentrated source of vitamins 
or mineral ingredients, or other substances demonstrating 
nutritious or other physiological effect, single or combined, 
traded in a form allowing dosing the substances, in the 
form of capsules, tablets, dragées, and other similar forms, 
pouches with powder, ampoules with liquid, bottles with 
a dropper, and other similar forms of liquids and powders 
intended for consumption in small, measured unit amounts, 
with the exclusion of medicinal products, as defined in 
the regulations of pharmaceutical law” [1]. However, other 
countries’ regulations describe diet supplements very in-
homogeneously, defining them as natural health products 
(NPH), supplementary medications, or nutritional supple-
ments. A product which is considered a diet supplement 
in one country, and to which the regulations of food safety 
apply, in another may be a therapeutic mean or a substance 
subject to strict control, and pharmaceutical law may regu-
late its production. The situation is complicated even more 
by the traditional medicine of Far-East countries, which 
may consider a diet supplement a substance which is not 
admitted for trading in other countries [2]. It is also to be-
lieve that many dietary supplements which are traditionally 
considered beneficial for health are lacking reliable proof 
that they affect, or studies examining such products are 
very limited in number.
Moreover, we must remember that nowadays, diet 
supplements are mostly compound products that con-
siderably hinder the definition of the potential effect of 
a given product on human’s health [2]. The above issues 
indicate the need to introduce reliable research in line with 
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evidence-based medicine (EBM) doctrine and concerning 
potential benefits of the use of diet supplements. This mat-
ter is particularly important in such a sensitive period as 
pregnancy, both from the developing child and maternal 
requirements, especially as regards the exposure to a meta-
bolic disorder such as gestational diabetes.
The aim of this study is to compare Polish and interna-
tional recommendations regarding dietary supplementa-
tion during pregnancy. 
METHODS
This review was conducted following the Preferred Re-
porting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) Statement checklist. Data search of this review 
was performed in the Web of Science and PubMed da-
tabases (“all databases search”). The combinations of the 
following terms were used: “dietary supplementation” or 
“vitamins supplementation” or “minerals supplementation” 
or “supplementation” or “diet supplementation” or “DHA” or 
“folic acid” or “PUFA” or “iron” or “vitamin D” or “magnesium” 
or “zinc” and “pregnancy” or “gestation”, or “polish society 
of gynecologists”, “polish gynecologist society”. The search 
criteria were narrowed down to articles with Polish affilia-
tion. Papers with another affiliation were included excep-
tionally, only if provided important information essential 
to interpret included articles. The initial screening of title, 
abstract, and keyword were performed using the follow-
ing filters: “supplementation”, “vitamins”, “minerals”, “Polish 
recommendations”, “polish society of gynecologists”, “polish 
gynecologist society”, “gestation”, “pregnancy”, “gestational”. 
We systematically and thoroughly examined the reference 
lists of searched publications to identify both direct and 
indirect evidence to meet the aim of the review. We included 
papers from 2009 to December 2019. Only publications that 
were conducted human-only (both review and clinical trial) 
were included. We excluded case reports. Studies with data 
duplications, not in English or Polish, not with Polish affilia-
tion, or published before 2009, were excluded.
From the Web of Science and PubMed databases (“all 
databases” search), 219 titles were found and assessed 
by two independent reviewers. After the titles were read, 
117 abstracts were excluded. The remaining 102 articles were 
screened, and 91 were excluded. After the selection process, 
a total of 11 articles were included in the review (Fig. 1).
The Polish Society of Gynaecologists and Obstetricians 
(PSGO) informs that, besides the recommendation concerning 
supplementation of folates, currently there are no separate 
guidelines on supplementation of microelements and vita-
mins in patients with gestational diabetes. However, the need 
to supplement vitamins and microelements in pregnancy after 
bariatric surgeries and partial gastrectomy is emphasized [3, 4].
RESULTS
The results of the literature review of the Polish recom-
mendations on the diet supplementation in pregnancy are 
presented in Table 1. 
Figure 1. PRISMA flow chart
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Table 1. Polish recommendations on the diet supplementation in pregnancy
No Ref. Supplementation recommendations
1 Wender-Ożegowska E, et al., 2018; [3]
Folic acid supplementation:
•	 women planning pregnancy should start taking folic acid at least 12 weeks before pregnancy and continue using 
it during pregnancy, puerperium, and lactation
•	 in women from the high-risk group (pre-pregnancy DM1 and DM2) the folates at a dose of 0.4 mg/day plus 
an additional 0.4 mg/day of active folates are recommended
Vitamin D supplementation:
•	 1500–2000 IU/day
2 Wender-Ożegowska E, et al., 2012; [4]
In pregnant women who have undergone bariatric surgery, deficiencies of iron, folic acid, vitamin B12, and calcium 
should be corrected
Supplementation should be continued during pregnancy and the postpartum period
3 Bomba-Opoń D, et al., 2017; [5]
Folic acid supplementation:
•	 every woman in reproductive age should include products rich in folates in her diet,
•	 the dose of folic acid depends on the risk of NTD (neural tube defects):
 — low risk: 0.4 mg/day,
 — intermediate risk (pre-diabetes DM1or DM2, obesity, bariatric surgery, metformin use) — 0.8 mg/day, active folates 
at least 12 weeks before conception and during pregnancy, puerperium and lactation period, 
 — high risk — 5 mg/day active folates in the preconception period and during the first trimester of pregnancy; 
0.8 mg/d in the second and third trimester, and during the breastfeeding period
•	 the active forms of folates and B12 vitamin supplementation are recommended
4 Polish Gynecological Society, 2014; [6]
Folic acid supplementation:
•	 constant supplementation at least 6 weeks before conception until the end of organogenesis
•	 the standard dose of folic acid 0.4 mg
•	 higher doses in women with obesity, megaloblastic anemia, smokers, women using hormonal contraception, anti-
epileptic drugs, hyperhomocysteinemia
DHA supplementation:
•	 600 mg for women who consume small amounts of fish
•	 up to 1000 mg for women at high risk of preterm labor
Iron supplementation: 
•	 women with iron deficiency anemia: 30 mg/day before conception, and then, from the end of the 8th week of 
pregnancy, increase the dose to a maximum of 60–120 mg/day
Iodine supplementation: 
•	 200 mg/day
Vitamin D supplementation: 
•	 2000 IU/day for women planning to become pregnant and pregnant
•	 the highest safe therapeutic dose: 10,000 IU
Mg: 
•	 600–1000 mg/day/depending on the indications
5 Poreba R, et al., 2011; [16] 
Folic acid supplementation:
•	 0.4 mg of folic acid/active form/supplementation is recommended for women planning pregnancy for at least 
6 weeks before it and until the end of the second trimester of pregnancy
Iron supplementation: 
•	 women with a high risk of iron deficiency anemia or with anemia should be supplemented with the iron before 
conception and then, from the 9th week of pregnancy
•	 standard daily doses: 18 mg/day before pregnancy, 26–27 mg in pregnancy, 20mg/day in breastfeeding period
Vitamin D supplementation:
•	 800–1000μg/day /in women with vitamin D deficiency
Magnesium supplementation:
•	 200–1000 mg/day /in women with magnesium deficiency
Iodine supplementation: 
•	 150 μg potassium iodide/in every pregnant woman
DHA supplementation: 
•	 200–300 mg/day DHA/in every pregnant woman
6 Dębski R, et al., 2013; [17]
Iron supplementation:
•	 women with a high risk of iron deficiency anemia or with anemia should be supplemented with the iron before 
conception and then, from the 9th week of pregnancy,
•	 standard daily doses: 18 mg/day before pregnancy, 26–27 mg in pregnancy, 20 mg/day in breastfeeding period
7 Horvath A, et al., 2007; [19]
DHA supplementation:
•	 due to the low level of consumption in Poland
•	 foods that are a natural source of omega-3 fatty, in women with low risk of preterm birth the supplementation at 
least 600 mg/day of DHA
•	 throughout pregnancy should be considered
•	 Women with a high risk of premature birth: at least 1000 mg DHA/day during all pregnancy period
→
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The comparison of the Polish recommendations, Ameri-
can College of Obstetricians and Gynecologists (ACOG) rec-
ommendations and National Institute for Health and Care 
Excellence/Royal College of Obstetricians and Gynaecolo-
gists (NICE/RCOG) recommendations on the diet supple-
mentation in pregnancy is presented in Table 2.
DISCUSSION
Folic acid supplementation during pregnancy
The essential diet supplement used in the preconcep-
tion period and during pregnancy is folic acid. 5-methyl-
tetrahydrofolate is an active form of folic acid in the body 
[5]. It is a coenzyme of nucleic acids transformations and 
a catalyst of blood formation processes. It is absorbed in 
the intestines. In blood circulation, it is bound to plasma 
proteins. A deficit in folic acid in the diet leads to the total 
consumption of its reserves within the body, as quickly as 
within four months [6]. Due to higher demand for folates 
during pregnancy, it may only be satisfied with well-com-
posed diet [7]. In breastfeeding women, the requirement for 
folic acid is even higher than during pregnancy [8].
In a pregnant woman, the deficit in folic acid may result 
in megaloblastic anaemia. It is caused by the reduced rate of 
DNA synthesis process and a prolonged period of red blood 
cells maturing in the marrow [6]. Diagnosis of megaloblastic 
anaemia is the indication for the increase of the supple-
mented dose of folic acid. The increased dose of folic acid 
should also be implemented in patients who smoke, have 
previously taken anti-epileptics, methotrexate, sulfasalazine, 
colestyramine or hormonal contraceptives. Also, in patients 
with celiac disease, Leśniowski-Crohn’s disease, ulcerative 
colitis, alcoholism, liver failure, kidney failure requiring di-
alysis, and patients with pre-eclampsia and/or IUGR (intra-
uterine growth restriction) in medical history. Women with 
hyperhomocysteinemia being the result of reduced activity 
of methylenetetrahydrofolate reductase (MTHFR) also re-
quire a higher supply of folic acid. The reasons for reduced 
MTHFR include different kinds of polymorphisms of MTHFR 
gene, among which the most frequent is polymorphism 
MTHFR 677 C > T, which occurs with the frequency reaching 
up to 50% in the Asian population [5, 6, 9]. Complications 
resulting from irregularities in the metabolic processes of 
folic acid, besides megaloblastic anaemia, include reoccur-
ring miscarriages and pre-eclampsia [5, 10, 11].
For the foetus, folic acid deficiency may result in a range 
of defects of the central nervous system, heart defects, 
urinary system obstructive defects, cleft lip and palate, 
increased risk of Down syndrome, and increased risk of 
miscarriage and thrombosis. Moreover, disturbances in the 
metabolic processes of folates may result in the inhibition 
of intrauterine growth of foetus [5, 6, 11, 12].
A cofactor of metabolic processes of folic acid is B12 vi-
tamin. The high concentration of folates with the coexisting 
insufficiency of B12 is particularly adverse. It may lead to 
hyperhomocysteinemia resulting in pregnancy complica-
tions. The use of too high doses of folic acids increases the 
risk of early pregnancy damage. It may cause the develop-
ment of insulin resistance, type 2 diabetes, and obesity in 
a child [5]. Current guidelines indicate that application of 
folic acid in a dose higher than 5mg is not justified and may 
Table 1. Polish recommendations on the diet supplementation in pregnancy, continued
No Ref. Supplementation recommendations
8 Charzewska J, et al., 2010; [20]
Vitamin D supplementation:
•	 800–1000 IU/d should be supplemented from the second trimester of pregnancy, if not adequate dietary supply 
and/or skin synthesis is provided
9 Płudowski P, et al., 2013; [21]
Vitamin D supplementation:
•	 women who plan pregnancy should start/maintain Vitamin D supplementation as recommended for adult,
•	 vitamin D supplementation of 1,500–2,000 IU/day (37.5–50.0 μg/day) should begin at least from the second 
trimester of pregnancy
•	 gynecologists/obstetricians should consider starting Vitamin D supplementation for pregnant women soon after 
the pregnancy is confirmed; if feasible, periodical monitoring of serum 25(OH)D concentration should be done to 
define optimum dosage and to verify the efficacy of supplementation
•	 the goal of supplementation is to achieve and maintain 25(OH)D concentration of 30–50 ng/mL (75–125 nmol/L)
10 Szybiński Z, 2012; [24]
Iodine supplementation:
•	 obligatory iodization of household salt (20–40 mg KI/1 kg) and neonates’ formula (10 μg/100 mL of milk)
•	 additional supplementation for pregnant and breastfeeding women with 150–200 μg of iodine as pharmacotherapy
11 Bednarek W, et al., 2010; [32]
DHA supplementation:
•	 women with low fish consumption and other sources of DHA: 500 mg of DHA/day for as little as the first month 
of pregnancy
•	 women with a high risk of premature birth: 1000 mg DHA/day
NTD — neural tube defects; DHA — docosahexaenoic acid; DM1 — diabetes mellitus type 1; DM2 — diabetes mellitus type 2
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Table 2. The comparison of the Polish recommendations, American College of Obstetricians and Gynecologists (ACOG) recommendations and 




The Polish Society of Gynaecologists 
and Obstetricians (PSGO) [3, 5, 6, 24, 32]
American College of Obstetricians 
and Gynecologists (ACOG) [33, 34]
National Institute for Health 
and Care Excellence/ Royal College 
of Obstetricians and Gynaecologists
(NICE/RCOG) [35–40]
Folic acid every woman in reproductive age should 
include products rich in folates in her 
diet,
the doses depend on the risk of NTD 
(neural tube defects):
low-risk — 0.4 mg/day
intermediate risk (pre-diabetes DM1 or 
DM2, obesity, bariatric surgery, metfor-
min use) — 0.8 mg/day, active folates 
at least 12 weeks before conception 
and during pregnancy, puerperium and 
lactation period 
high risk — 5 mg/day active folates in 
the preconception period and during 
the first trimester of pregnancy; 0.8 mg/d 
in the second and third trimester, and 
during the breastfeeding period, 
the active forms of folates and B12 vitamin 
supplementation are recommended
all  women capable of  becoming 
pregnant should strive for intake of 
400 μg (0.4 mg) of folic acid daily, in the 
form of a supplement, multivitamin, 
consumption of fortified foods, or 
a combination of the above. 
during pregnancy: 0.6 mg/day
women who have had a previous 
NTD-affected pregnancy, who are 
themselves affected, have a first- or 
second-degree relative with a NTD, or 
who have DM1 should take 4 mg of 
folic acid commencing 3 months before 
conception and continuing throughout 
the first trimester
standard dose: 400 μg/day), ideally 
before conceiving and continue to 13th 
week of pregnancy
women with high risk of NTD: 5 mg/day 
of folic acid
Iron women with iron deficiency anemia: 
30 mg/day before conception, and 
then, from the end of the 8th week 
of pregnancy, increase the dose to 
a maximum of 60–120 mg/day
women with a high risk of iron deficiency 
anemia in pregnancy and breastfeeding 
period: 18 mg/day before conception, 
26–27 mg/day during pregnancy, 
20 mg/day during lactation
standard dose: 27 mg/day iron supplementation should not be 
offered routinely to all pregnant women. 
it does not benefit the mother’s or the 
baby’s health and may have unpleasant 
maternal side effects
magnesium 200–1000 mg/day in women with a low 
level of magnesium in the blood serum 
or symptoms of magnesium deficiency
N/A N/A
iodine 150–200 µg/day 200 µg/day N/A
vitamin D 1500–2000 IU/day (4000 IU/day in 
women with obesity)
In pregnant women with increased risk 
of vitamin D deficiency, maternal serum 
25-hydroxyvitamin D levels can be 
considered and should be interpreted 
in the context of the individual clinical 
circumstance
when vitamin D deficiency is iden-
t i f ied dur ing pregnanc y,  1 .000– 
–2.000 international units per day of 
vitamin D is safe
all pregnant and breastfeeding women 
— 10 micrograms/day 
women with high-risk of vitamin D 
deficiency: at least 1000 IU/d (women 
with increased skin pigmentation,
reduced exposure to sunlight, or those 
who are socially excluded or obese)
women with vitamin D deficiency 
— treatment for 4–6 weeks, either
with cholecalciferol 20 000 IU/ week or 
ergocalciferol 10 000 IU/ twice a week, 
followed by standard
supplementation
DHA 600 mg for women who consume small 
amounts of fish, 
up to 1000 mg for women at high risk of 
preterm labor,
N/A N/A
N/A – not applicable; NTD — neural tube defects; DHA — docosahexaenoic acid; DM1 — diabetes mellitus type 1; DM2 — diabetes mellitus type 2
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lower the seizure threshold [5, 13]. Folic acid supplementa-
tion should be avoided in elderly patients and in neoplastic 
diseases as it may intensify the oncogenesis [6].
Folic acid supplementation considerably reduces the risk 
of neural tube defect, heart defect, urinary system and limbs 
defect, cleft lip and palate, and pre-eclampsia [5]. Therefore, 
it is recommended by PSGO that every woman in repro-
ductive age should include products rich in folates (e.g., 
lettuce, cabbage, nuts) and food enriched with this nutrient 
in her diet. PSGO has qualified patients with pre-diabetes, 
diabetes mellitus type 1 or type 2, obese patients, as well 
as women after bariatric surgery and patients using metfor-
min as the group of intermediate risk of developing foetus 
defects. The previous studies have shown that both hyper-
glycaemia and insulin resistance may cause a disturbance 
in folates metabolism [5, 14]. For that group of women, 
PSGO recommends that folic acid should be supplemented 
at least 12 weeks before conception and continued during 
pregnancy, puerperium and lactation period. The recom-
mended dose of folates for that population of patients is 
0.8 mg/day, including active folates. PSGO recommends 
the use of preparations with documented composition and 
effect, and supplementation of B12 [3, 5]. 
If a patient with diabetes mellitus (DM) has given birth 
to a child with neural tube defect, according to PSGO guide-
lines, she belongs to the group of women with a high risk 
of giving birth to another child with neural tube defect. In 
such population, PSGO recommends folates supplementa-
tion in the dose of 5 mg a day in the preconception period 
and during the first trimester of pregnancy. In the second 
and third trimester, and during the breastfeeding period, 
the dose of folates should be reduced to 0.8 mg/day. It is 
recommended that active forms of folates and B12 vitamin 
supplementation are considered [5]. 
American College of Obstetricians and Gynecologists 
(ACOG) recommends that all women capable of becoming 
pregnant should strive for intake of 400 μg (0.4 mg) of folic 
acid daily, in the form of a supplement, multivitamin, con-
sumption of fortified foods, or a combination of the above. 
The dose recommended during pregnancy is 0.6 mg/day. 
Women who have had a previous NTD-affected pregnancy, 
who are themselves affected, whose first- or second-degree 
relative has NTD, or suffering from DM1 should take 4 mg 
of folic acid commencing three months before conception 
and continuing throughout the first trimester [34].
National Institute for Health and Care Excellence/Royal 
College of Obstetricians and Gynaecologists (NICE/RCOG) 
recommends a standard dose of 400 μg/day of folic acid 
before conceive and continue the supplementation until 
13th week of pregnancy. Women with high risk of NTD should 
take 5mg/day of folic acid [35, 37, 39].
Iron supplementation during pregnancy
Pregnant women often demonstrate iron deficiency 
anaemia and the so-called physiological anaemia result-
ing from haematocrit drop. Anaemia resulting from iron 
deficiency is recognised when the haemoglobin concen-
tration is below 11 mg%. Anaemia during pregnancy leads 
to reduced tolerance to effort, tiredness and increased risk 
of premature birth. A drop in the iron content in feeding 
mother’s milk may result in anaemia and reduced psycho-
motor development of the child [6]. Risk factors of iron 
deficiency in mother include vegetarian or vegan diet, heavy 
menstrual bleeding, lactation, malabsorption, and the preg-
nancy itself [6, 15].
In women who are not pregnant, iron content in the 
diet should amount to no less than 18 mg/day, during preg-
nancy 26–27 mg/day and 20 mg/day during lactation [16]. 
British Committee for Standards in Haematology indicates 
that iron supplementation is required in patients with hae-
moglobin level below 11.0 g% in the first trimester, below 
10.5 g% in the second or third trimester, below 10 g% dur-
ing puerperium or lactation period, or with ferritin level 
below 30 mg/L [17, 18]. Women with anaemia should start 
oral supplementation of iron during the pregnancy plan-
ning period. After the conception, they should begin iron 
supplementation after the eight weeks of pregnancy, in 
a daily dose of 30 mg. Afterwards, depending on the anae-
mia level, the dose should be increased to 60–120 mg/day. 
Iron supplementation before the eighth week of pregnancy 
may cause a high concentration of iron in vesicular fluid, 
which can harm the development of an embryo and cause 
developmental defects [6, 19]. Specialists emphasize that 
the most beneficial form of oral iron supplementation is sup-
plying it in small doses over a long period. It is dependent on 
the metabolism of proteins responsible for iron transport in 
blood circulation. Moreover, during iron supplementation, 
it is essential to ensure proper supply of magnesium and 
B6 vitamin [6, 15]. Absorption of non-heme iron is assisted 
by vitamin C [17]. 
Iron supplementation is also recommended in women 
in the preconception period in which the risk of anaemia 
in the future is present. Moreover, PSGO recommends iron 
supplementation in pregnant women with the risk of iron 
deficiency anaemia and during the lactation. In the situa-
tions mentioned above the doses of iron supplement should 
be 18 mg before conception, 26–27 mg during pregnancy, 
and 20 mg during breastfeeding [6, 17].
PSGO experts recommend the use of iron bis-glycinate 
both to prevent and treat anaemia in obstetrics and gyn-
aecology [17]. PSGO also points out to numerous benefits, 
including efficiency and the safety of use of low-dose heme 
iron preparations. PSGO emphasize that iron supplementa-
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tion may be individually adjusted with the use of different 
preparations of various pharmacological properties [17].
ACOG recommends that pregnant women should take 
a standard dose: 27 mg/day of iron [33, 34]. NICE/RCOG 
states that iron supplementation should not be offered 
routinely to all pregnant women. Moreover, according to 
NICE/RCOG iron supplementation during pregnancy does 
not benefit the mother’s or the baby’s health and may even 
has unpleasant maternal side effects [35, 39].
Vitamin D supplementation during pregnancy
Vitamin D regulates calcium and phosphorus concen-
tration in blood. It is responsible for mineral density of 
skeleton, reduces excessive proliferation, stimulates the 
development of cells in the hematopoietic system, and 
plays an immunomodulatory role [6]. Vitamin D is produced 
in human skin during exposure to sunlight. However, in 
Poland, such exposure is somewhat limited, which consid-
erably reduces the production of vitamin D in the body [6]. 
Vitamin D insufficiency disturbs calcium and phosphate 
homeostasis and may be a cause of osteoporosis. Pregnant 
and lactating women are the group particularly susceptible 
to the inadequacy of that nutrient [6]. A correlation between 
vitamin D insufficiency and glucose tolerance disturbances 
and diabetes mellitus type 2 has been confirmed. Vitamin D 
insufficiency in Polish population is widespread [20]. There-
fore, PSGO recommends the measurement of 25-OH-D3, 
especially in pregnant women with diabetes diagnosed 
during pregnancy, gestational diabetes in the early preg-
nancy, or obese pregnant women with hyperglycaemia 
during pregnancy. Standard recommended dose of vita-
min D for a pregnant woman is 1.5–2 000 IU/d. Whereas, in 
an obese patient, it is recommended to use a daily dose of 
up to 4 000 IU/day [3, 21]. The highest clinically safe dose 
of vitamin D is 10 000 IU/day [6].
ACOG claims that when vitamin D deficiency is identi-
fied during pregnancy, a dose of 1 000–2 000 international 
units per day of vitamin D is safe [33]. NICE/RCOG recom-
mends 10 micrograms/day of vitamin D to all pregnant and 
breastfeeding women. Women with high-risk of vitamin D 
deficiency should take at least 1 000 IU/day — these are 
women with increased skin pigmentation, reduced expo-
sure to sunlight, or those who are socially excluded or obese. 
In women with vitamin D deficiency a 4–6 weeks-long treat-
ment, either with cholecalciferol 20 000 IU/week or ergo-
calciferol 10 000 IU/twice a week, should be followed by 
standard supplementation [35–40].
Magnesium supplementation during pregnancy
Magnesium is responsible for the regulation of neuro-
muscular transmission and regulations of minerals manage-
ment in the skeleton. Magnesium insufficiency increases 
muscle contractility demonstrated by painful contractions. 
It also leads to an elevated risk of arterial hypertension. 
Human body demand for this element is 6 mg/kg/day and 
doubles during pregnancy and breastfeeding period. Mag-
nesium supplementation is recommended in the condition 
of its reduced concentration in blood, or case of clinical 
manifestations of the insufficiency. Magnesium is supple-
mented orally in a daily dose of 200 to 1000 mg, depending 
on the indications [6, 16, 22, 23].
No ACOG or NICE/RCOG recommendations on mag-
nesium supplementation in pregnancy have been found.
Iodine supplementation during pregnancy
The risk of too low supply of iodine in the diet in Poland 
has become the basis for preventive supplementation of 
iodine in kitchen salt. Iodine demand during pregnancy in-
creases and the recommendation for pregnant women to re-
duce salt content in their food may intensify the insufficiency 
[24, 25]. Iodine insufficiency may result in the occurrence of 
thyroid goitre, increased risk of central nervous system dam-
age, hearing impairment, and mental disorders of the child. 
In a pregnant woman, hypothyroidism leads to an increased 
risk of premature birth and miscarriages. It may also result 
in hypothyroidism of the foetus and newborn child [24, 26].
In the first trimester of pregnancy, daily demand for 
iodine increases to about 200 µg. Breastfeeding is also the 
reason for the high need for this element. Recommended 
daily dose of iodine supplementation in pregnancy plan-
ning, pregnant and lactating women is 200 µg [6]. According 
to WHO (World Health Organisation), the treatment in preg-
nant and lactating women may amount to 200–500 µg [27].
ACOG recommends a daily dose of 200 µg of iodine 
during pregnancy [34].
Polyunsaturated fatty acids during pregnancy
PUFA (polyunsaturated fatty acids) are the components 
of phospholipid membranes. Proper supply of PUFA dur-
ing pregnancy contributes to the extension of pregnancy 
duration, increased body mass of the newborn child with-
out the risk of macrosomia, and reduced risk of premature 
birth [6]. It has been demonstrated that omega-3 acids 
supply minimises the occurrence of diabetes mellitus type 1, 
allergies and hypertension in adult life [28]. The most crucial 
omega-3 acid during pregnancy and lactating period is 
docosahexaenoic acid (DHA) present in seafood, algae, and 
fatty sea fish. Proper DHA supply during pregnancy and lac-
tation results in undisturbed psychomotor development of 
the child. It also beneficially modifies the risk of postpartum 
depression in women. Favorable effects of DHA supply in 
pregnancy have been emphasized by European Food Safety 
Authority (EFSA) [6, 29]. PUFA supply demonstrates a posi-
tive impact on the cardiovascular system, reducing inflam-
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matory condition in atherosclerotic plaques or decreasing 
triglyceride and low-density lipoprotein (LDL) cholesterol 
levels in blood [30].
PSGO recommends that in case of limited consumption 
of DHA in pregnant women’s diet, at least 600 mg of DHA 
should be supplemented every day. In case of the high risk 
of premature birth — at least 1000 mg DHA a day during 
the entire pregnancy period should be taken. DHA supple-
mentation is recommended at least from the 20th week of 
pregnancy [6, 31]. Considering the effect of DHA on the 
child’s development, it is recommended to supplement 
DHA during breastfeeding period to maintain its optimal 
content in the milk. It is emphasized that DHA source should 
be safe and controlled, to prevent potential poisoning with 
heavy metals, dioxins and polychlorinated biphenyls (PCBs), 
resulting from impurities. The reliable source of DHA should 
be small fish and algae of the type Schizochytriumsp grown 
under artificial conditions [6, 15, 32].
The numerous studies have shown that DHA supple-
mentation prolongs the duration of pregnancy and in-
creases the birth weight of the child. The mechanisms of 
that phenomenon are based on reduced production 
of prostaglandins E2 and F2 by omega-3 acids and stabiliza-
tion of cell membranes [15]. 
No current ACOG or NICE/RCOG recommendations on 
DHA supplementation in pregnancy have been found.
CONCLUSIONS
In the light of current Polish recommendation, the 
dietary supplementation of folates, vitamin D and iodine 
is recommended in every pregnant woman. Additionally, 
PSGO highlighted the benefits of iron supplementation in 
pregnant women with anaemia or at high risk of develop-
ing anaemia. Magnesium supplementation is needed in the 
condition of its reduced level in blood. In the case of limited 
consumption of DHA in pregnant women’s diet and a group 
of pregnant women with a high risk of premature birth, DHA 
supplementation is also recommended.
PSGO, ACOG and NICE/RCOG recommend a standard 
dose of 0.4 mg/day of folic acid in women at low NTD risk. 
However, only PSGO considers a group of women at inter-
mediate risk, in which a dose of 0.8 mg/day of active folates 
is recommended. In women at high NTD risk both PSGO and 
NICE/RCOG recommend 5 mg/day of folates, while in such 
case ACOG recommends 4 mg/day.
PSGO recommends iron supplementation during preg-
nancy and lactation depending on the woman’s iron status, 
while ACOG advise a standard dose of 27 mg/day of iron. 
NICE/RCOG does not recommend iron supplementation 
routinely during pregnancy. 
PSGO recommends 150–200 µg of iodine daily during 
pregnancy, similarly ACOG advices a daily dose of 200 ug 
of iodine. NICE/RCOG did not develop recommendations of 
iodine supply during pregnancy.
In relation to vitamin D supplementation in pregnancy 
PSGO advices 1500-2000 IU/day (4000 IU/day in women 
with obesity). Similarly, ACOG states that in vitamin D defi-
ciency a dose of 1000–2000 IU of vitamin D per day is safe. 
NICE/RCOG recommends a dose of 10 micrograms/day of 
vitamin D to all pregnant and breastfeeding women; at least 
1000 IU/day to women with high-risk of vitamin D deficien-
cy; and 20 000 IU/week of cholecalciferol or 10 000 IU/twice 
a week of ergocalciferol, followed by standard supplementa-
tion to women with vitamin D deficiency.
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